|
The Coordinating Group for Project ImpACT
consists of the Project Staff and local
members
of the Advisory Board.
Steven N. Goodman, MD, MHS, PhD
Principal Investigator
Harry M. Marks, PhD
Co-Principal Investigator
Karen A. Robinson, MSc
Project Coordinator
Verna Scheeler, MLA
Project Manager
Alla Guseynova, MS
Database programmer
Additional personnel
In addition to those named above, fellows and graduate students from The
Center for Clinical Trials and the Program
in the History of Science, Medicine and Technology participate in and
contribute to Project ImpACT.
Current staff
Allison Brown
Emily Evans
Gila Neta
Olaide Odelola
Former staff
Nyasha Bakare (2006)
Juliana Cuervo (2007)
Lara Devgan (2006-2007)
Ishveena Duggal (2004)
Julia Gage (2005-2006)
Emily Henkle (2006)
Jay Herson (2005)
David Majure (2006-2007)
Tram Lam (2005-2006)
Sara Lowther (2005-2007)
Nancy Maldeis (2004-2005)
Todd Meyers (2005)
Kamal Patel (2006)
Sarah Post (2003)
Samara Rifkin (2006)
Jordana Rothschild (2004)
Lauren Singer (2004)
Ellen Wasserman (2003-2005)
Lashawn Worsley (2005)
Return to top of page.
The International Advisory Board is composed of persons knowledgeable
in the fields of clinical trials, statistics, medicine, medical
journalism, ethics and the history of medicine. They are listed
below and further details are available by clicking on each name.
Those marked with an astericks (*) are, along with the Project
Staff, members of the Coordinating Group.
- John Bailar III, MD, PhD
- David Brown, MD *
- Sir Iain Chalmers, MBBS, MSc
- Kay Dickersin, PhD
- Benjamin Djulbegovic, MD, PhD
- Sir Richard Doll, MD, DSc
- Susan Ellenberg, PhD
- Norman Fost, MD, MPH
- Barbara S. Hawkins, PhD *
- Brian Haynes MD, PhD
- Joseph Lau, MD
- Curtis L. Meinert, PhD *
- Steven Piantadosi, MD, PhD *
- David L. Sackett, MD, OC, FRSC, FRCP
- Jonathan M. Samet, MD, MS *
- Harold Sox, MD, MACP
- Sean Tunis, MD, MSc *
- Jan P. Vandenbroucke, MD, PhD
- Janet Wittes, PhD
Return to top of page.
Details about Project Staff and Advisory Board
Steven N. Goodman, MD, MHS, PhD
Principal Investigator
Dr. Goodman has been on the Johns Hopkins faculty as designer, analyst and
teacher of clinical trials and related methodologies for 14 years. At Johns
Hopkins, he is co-director of the AHRQ designated Evidence-based Practice Center,
and is on the faculties of the Center for Clinical Trials, the Graduate Program
in Clinical Investigation, and the Bioethics Institute. He is the Editor of
Clinical Trials, the official journal of the Society for Clinical Trials (SCT),
and serves on the SCT Board of Directors. He has served as a statistical editor
of the Annals of Internal Medicine since 1987 and was Associate Director of
the Baltimore Cochrane Center from 1994-98. He is a member of the Medicare
Coverage Advisory Commission for the Centers for Medicaid and Medicare Services,
and he serves on the Medical Advisory Panel for the National Blue Cross/Shield
Technology Assessment Program.
Harry M. Marks, PhD
Co-Principal Investigator
Dr. Marks occupies the Elizabeth Treide and A. McGehee Harvey Professorship
in the Department of the History of Science, Medicine and Technology, Johns
Hopkins University. He is the author of The Progress of Experiment: Science
and Therapeutic Reform in the US, 1900- 1990. He is a member of the Council
of the American Association for the History of Medicine and has served on the
editorial boards of Isis and the Bulletin of the History of Medicine, the two
major journals in history of science and history of medicine.
Karen A. Robinson, MSc
Project Coordinator
Ms. Robinson, a faculty member in medicine at the Johns Hopkins University,
is co- director of the AHRQ designated Evidence-based Practice Center (EPC).
She previously served as Project Director for the Johns Hopkins EPC and for
the Endocrine Cost-Effectiveness Study. She is an editor for the Cochrane Methodology
Review Group (CMRG) and is a member of the international advisory board overseeing
the development of the Cochrane Central Register of Controlled Trials.
Verna Scheeler, MLA
Project Manager
Ms. Scheeler is the managing editor of Clinical Trials, the
official journal of the Society for Clinical Trials (SCT). Formerly, she was
the assistant editor of HopkinsHealth, the consumer health information content
licensing service of the Johns Hopkins University
and Health System.
Alla Guseynova, MS
Database programmer
Ms. Guseynova is a Senior Database Analyst within the Johns Hopkins Oncology
Center Clinical Research Office (CRO). She has developed and maintains web-based
database applications for a broad variety of applications and projects with
the Oncology Center, including their Protocol Library, the Lymphoma Database,
Prostate Cancer Database, Tissue Procurement Database, and various administrative
databases.
Return to top of page.
International Advisory Board
John Bailar III, MD, PhD is
Professor Emeritus, University of Chicago. He was statistical
consultant to the New England Journal of Medicine 1980-91, was
on their Board of Editors 1993-2000 and was a MacArthur Fellow
from 1990 to 1995. He is an elected member of the Institute of
Medicine and the International Statistical Institute. His professional
interests have centered on the causes and prevention of cancer,
and more recently on the broad role of statistics in science.
David Brown, MD *is a medical
reporter for the Washington Post, focusing on issues relating
to medical research and policy. He is a member of the American
College of Physicians and a winner of the William Carlos Williams
Poetry Prize.
Sir Iain Chalmers, MBBS, MSc directed
the National Perinatal Epidemiology
Unit between 1978 and 1992, and the UK Cochrane Centre between
1992 and
2002. His main current interests are the history of the development
of
methods to test the effects of medical treatments, and in promoting
public understanding of these methods. He is Editor of The
James Lind
Library, which documents the evolution
of
fair tests of medical treatments.
Return to top of page.
Kay Dickersin, PhD is
Associate Professor at Brown University in the Department of
Community Health. Dr. Dickersin is Director of the United States
Cochrane Center. She convenes the Cochrane Central Register of
Controlled Trials Advisory Group and serves as an editor of the
Eyes and Vision Collaborative Review Group. She is also co-founder
of Project LEAD, a program that brings together leading world
experts in breast cancer treatment, epidemiology and biology
to teach breast cancer activists about the science and the most
recent research findings in the field.
Benjamin Djulbegovic, MD, PhD is
Associate Professor of Oncology and Medicine at the H. Lee Moffit
Cancer Center and Research Institute, University of South Florida.
Dr. Djulbegovic also maintains a website of clinical decision
making tools that includes a listing of important clinical trials.
Sir Richard Doll, MD, DSc (1912-2005).
We are grateful for Sir Richard Doll's contributions to this project, and for
his contributions to epidemiology and public health. He was a world renowned physician,
epidemiologist and clinical trials expert who published some of the
earliest and most influential work on the link between smoking and
cancer. He knew personally and worked with many of the earliest clinical
trial investigators, including Sir Austin Bradford Hill. From 1983 until
his death he served as an Honorary Consultant at the Imperial cancer
Research Fund Cancer Studies Unit, Radcliffe Infirmary, Oxford.
Return to top of page.
Susan Ellenberg, PhD is
Director of the Office of Biostatistics and Epidemiology at the
U.S. Food and Drug Administration, in the Center for Biologics
Evaluation and Research. She played a leading role in the development
of international standards for clinical trials performed by the
pharmaceutical industry. She is a Fellow of the American Statistical
Association and the American Association for the Advancement
of Science, and is an elected member of the International Statistical
Institute.
Norman Fost, MD, MPH is
Professor of Pediatrics at the University of Wisconsin where
he is Professor of Pediatrics, Director of the Program in Medical
Ethics in the Department of the History of Medicine, and works
as a general pediatrician. He is Chairman of the Hospital Ethics
Committee, Chairman of the Human Subjects Committee, and heads
the Child Protection Team.
Barbara S. Hawkins, PhD * is
Professor of Ophthalmology at Johns Hopkins University where
she has been a member of The Wilmer Ophthalmological Institute
since 1981. She directs the Clinical Trials and Biometry Division,
is Associate Director of the Johns Hopkins Center for Clinical
Trials, and has been active in the Society for Clinical Trials.
Brian Haynes MD, PhD is Professor of Clinical Epidemiology and Medicine, Michael
Gent Professor and Chair of the Department of Clinical Epidemiology and
Biostatistics and Chief of the Health Information Research Unit at
McMaster University, and on the active medical staff of Hamilton Health
Sciences, Hamilton Ontario. His main research interests are in improving
health and health care through enhancing the validation, distillation,
dissemination and application of health care knowledge. He is one of the
originators of evidence-based medicine and is founding editor of ACP
Journal Club, Evidence-Based Medicine, and BMJUpdates+, has been on the
editorial board of the BMJ, and is on the Board of Trustees of BioMed
Central.
Return to top of page.
Joseph Lau, MD is Professor
of Medicine at Tufts University School of Medicine and Professor
of Clinical Care Research at the Sackler School of Graduate Biomedical
Sciences. He is the director of one of the AHRQ designated Evidence-based
Practice Centers and the United States Cochrane Center (Boston
Branch).
Curtis L. Meinert, PhD * is
Professor of Epidemiology at the Johns Hopkins Bloomberg School
of Public Health, where he is the founder and Director of the
Center for Clinical Trials. Dr. Meinert was a founding member
of The Society for Clinical Trials and served as Editor-in-Chief
of the journal Controlled Clinical Trials for its first ten years,
from 1981-1992.
Steven Piantadosi, MD, PhD * is
Professor of Oncology and Biostatistics at the Johns Hopkins
School of Medicine, and Director of the Division of Biostatistics
and Clinical Trials, Johns Hopkins Oncology Center.
Return to top of page.
David L. Sackett, MD, OC, FRSC, FRCP was
founding Chair of Clinical Epidemiology at Oxford, founding Chair
of Clinical Epidemiology & Biostatistics at McMaster, founding
Director of the NHS R&D Centre for Evidence-Based Medicine at
Oxford and founding co- editor of the medical journal Evidence-based
Medicine. He currently directs the Trout Research and Education
Centre in Canada.
Jonathan M. Samet, MD, MS * is
Professor and Chair of the Department of Epidemiology of the
Johns Hopkins University Bloomberg School of Public Health where
he is also Director of the Institute for Global Tobacco Control.
He has served on the Science Advisory Board for the U.S. Environmental
Protection Agency and is Chair of the National Research Council's
Committee on Research Priorities for Airborne Particulate Matter.
He was chair of the IOM BEIR VI panel (Health Effects of Radon),
and the 2001 and 2002 Surgeon General reports on the health effects
of direct and passive smoking. He was elected to the Institute
of Medicine of the National Academy of Sciences in 1997.
Harold Sox, MD, MACP is Editor
of the Annals of Internal Medicine. Dr. Sox was the President
of the American College of Physicians-American Society of Internal
Medicine during 1998- 1999. He chaired the U.S. Preventive Services
Task Force from 1990 to 1995, the Institute of Medicine Committee
to Study HIV Transmission through Blood Products, and the Institute
of Medicine Committee on Health Effects Associated with Exposures
Experienced in the Gulf War. He chairs the Medicare Coverage
Advisory Committee of the Center for Medicare Services. He was
elected to the Institute of Medicine of the National Academy
of Sciences in 1993.
Return to top of page.
Sean Tunis, MD, MSc *,
is Director, Center for Medical Technology
Policy, San Francisco, CA. Dr. Tunis is the former Deputy Director
of
the Office of Clinical Standards and Quality (OCSQ) and Chief
Clinical
Officer at the Centers for Medicare and Medicaid Services (CMS).
Dr.
Tunis also served as the Director of the Health Program at the
Congressional Office of Technology Assessment and as a health
policy
advisor to the U.S. Senate Committee on Labor and Human Resources,
where
he participated in policy development regarding pharmaceutical
and
device regulation.
Jan P. Vandenbroucke, MD, PhD is
Professor of Clinical Epidemiology at Leiden University, The
Netherlands and also Visiting Professor at the University of
Leuven, Belgium. He has served on editorial and advisory boards
of several key journals including The Lancet and Epidemiology.
He was co-editor of the Journal of Clinical Epidemiology.
Janet Wittes, PhD is the
President of Statistics Collaborative, Inc., a firm in Washington
DC that specializes in the design and analysis of randomized
clinical trials. She was previously Chief of Biostatistics Research
Branch at the National Heart, Lung and Blood Institute, US National
Institutes of Health. She is a Fellow of the American Statistical
Association and the American Association for the Advancement
of Sciences and an elected member of the International Statistical
Institute. She is the immediate past-President of the Society
for Clinical Trials and formerly served as Editor-in-Chief of
the Society's official journal, Controlled Clinical Trials from
1995-1999.
Return to top of page.
|
